Zurich Insurance Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.9M Buy
+22,651
New +$11.9M 0.09% 130
2025
Q1
Sell
-23,784
Closed -$16.9M 292
2024
Q4
$16.9M Sell
23,784
-39,857
-63% -$28.4M 0.14% 129
2024
Q3
$66.9M Sell
63,641
-28,709
-31% -$30.2M 0.57% 60
2024
Q2
$97.1M Buy
92,350
+39,382
+74% +$41.4M 0.84% 30
2024
Q1
$51M Buy
52,968
+20,736
+64% +$20M 0.47% 73
2023
Q4
$28.3M Sell
32,232
-47,092
-59% -$41.4M 0.29% 103
2023
Q3
$65.3M Buy
+79,324
New +$65.3M 0.69% 49
2019
Q4
Sell
-14,187
Closed -$3.94M 434
2019
Q3
$3.94M Buy
14,187
+468
+3% +$130K 0.07% 277
2019
Q2
$4.29M Buy
13,719
+541
+4% +$169K 0.09% 262
2019
Q1
$5.41M Sell
13,178
-15,620
-54% -$6.41M 0.12% 219
2018
Q4
$10.8M Buy
28,798
+5,471
+23% +$2.04M 0.26% 114
2018
Q3
$9.43M Sell
23,327
-75
-0.3% -$30.3K 0.2% 140
2018
Q2
$8.07M Buy
23,402
+13,625
+139% +$4.7M 0.18% 162
2018
Q1
$3.37M Sell
9,777
-1,443
-13% -$497K 0.08% 310
2017
Q4
$4.22M Buy
11,220
+1,379
+14% +$518K 0.1% 247
2017
Q3
$4.4M Sell
9,841
-2,276
-19% -$1.02M 0.12% 202
2017
Q2
$5.95M Sell
12,117
-561
-4% -$276K 0.17% 147
2017
Q1
$4.91M Sell
12,678
-483
-4% -$187K 0.14% 179
2016
Q4
$4.83M Buy
13,161
+945
+8% +$347K 0.15% 170
2016
Q3
$4.91M Buy
12,216
+3,539
+41% +$1.42M 0.16% 166
2016
Q2
$3.03M Buy
8,677
+1,442
+20% +$504K 0.11% 221
2016
Q1
$2.61M Sell
7,235
-11,830
-62% -$4.26M 0.09% 238
2015
Q4
$10.4M Buy
19,065
+1,271
+7% +$690K 0.37% 81
2015
Q3
$8.28M Buy
+17,794
New +$8.28M 0.3% 111